4893 items matching your search terms.

The Heart Protection study: results and clinical implications for treatment of patients in the Asia-Pacific

Keech, AC

PPAR alpha agonists in the treatment of diabetes

Keech, AC

The Heart Protection Study and implications for international lipid guidelines

Keech, AC

Developing evidence-based practice in diabetes care: an update on the FIELD study

Keech, AC

Recent advances in clinical trials for treatment of atherosclerosis in diabetes

Keech, AC

Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes of impaired fasting glucose: Results from the LIPID trial

Keech, A. Colquhoun, D. Best, J. Kirby, A. Simes, R. J. Hunt, D. Hague, W. Beller, E. Arulchelvam, M. Baker, J. Tonkin, A.
DIABETES CARE, 2003     DOI:10.2337/diacare.26.10.2713

Managing the resource demands of a large sample size in clinical trials: can you succeed with fewer subjects [letter]

Keech, AC Gebski, VJ

Significant lipid changes in a large-scale trial of fenofibrate on cardiovascular disease in type 2 diabetes

Keech, AC; Best, JD; Scott, RS; Barter, PJ; Forder, P; Taskinen, M-R; Simes, RJ

Significant lipid changes in a large-scale trial of fenofibrate on cardiovascular disease in type 2 diabetes. The FIELD Study Investigators

Keech, AC; Best, JD; Scott, RS; Barter, PJ; Simes, RJ; Forder, P; Taskinen, M-R

Significant lipid changes in a large-scale trial of fenofibrate to prevent cardiovascular disease in type 2 diabetes. The FIELD Study Investigators

Keech, AC; Best, JD; Scott, RS; Barter, PJ; Simes, RJ; Forder, P; Taskinen, M-R

FIELD: Where do we stand? Significant lipid changes in a large-scale trial of fenofibrate to prevent cardiovascular disease in type 2 diabetes

Keech, A; Best, J; Scott, R; Barter, P; Forder, P; Taskinen, MR; Simes, RJ

Metabolic syndrome, best identified by obesity and dysglycemia, is associated with greater benefits of pravastatin in patients with coronary disease: the LIPID trial

Keech, AC; Colquhoun, D; Kirby, AC; Best, J; Simes, RJ; Tonkin, A; for the LIPID Study investigators,

Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose: results from the LIPID trial

Keech, AC; Colquhoun, D; Best, J; Kirby, A; Simes, RJ; Hunt, D; Hague, W; Beller, E; Arulchelvam, M; Baker, J; Tonkin, A; for the LIPID study group,

Evidence-based interpretation guidelines for health-related quality of life measures: a novel application of meta-analysis illustrated with the FACT-G

King, M. T. Stockler, M. R. Cella, D. F. Osoba, D. Eton, D. Eisenstein, A. Thompson, J. F.

Determining the sample size in a clinical trial [letter]

Kirby, A Gebski, V Keech, AC